12:00 AM
May 11, 2009
 |  BC Week In Review  |  Company News  |  Other News

Evotec neurology news

Evotec will restructure and reduce headcount for the second time in two months, restructuring its drug discovery and development operations and cutting headcount by about 45 (12%) to less than 330 to save cash. The cuts will...

Read the full 163 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >